Philips received a complaint on the heartstart xl+ defibrillator indicating that there was an ecg lead detection failure.A philips field service engineer (fse) evaluated the device onsite and determined that a self-test needed to be performed.Following the self-test, the device was fully functional and returned to use.Based on the information available and the testing conducted, no fault was found with the device following a self-test.The device remains at the customer's site.The investigation concludes that no further action is required at this time.If additional information is received the complaint file will be reopened.
|